Last edition
News about "RedHill Biopharma "
RedHill Biopharma Divests Talicia Business to Apotex for USD 18 Million Upfront
RedHill Biopharma has divested its 70 percent interest in Talicia to Apotex in a deal valued at up to USD 53 million, including potential sales milestones.
RedHill Biopharma | 01/09/2026 | By News Bureau
RedHill Biopharma Closes Private Placement of up to USD 19.4 Million
RedHill Biopharma has closed a private placement worth up to USD 19.4 million, including USD 6 million upfront and up to USD 13.4 million in additional proceeds from the full exercise of warrants.
RedHill Biopharma | 23/06/2026 | By News Bureau | 116
RedHill Biopharma Bags Funding Through BARDA to Advance Opaganib for Ebola Treatment
Under this cost-sharing contract, BARDA will provide partial funding for the company to further advance opaganib to mitigate infection and contain EBOV outbreaks.
RedHill Biopharma | 15/10/2024 | By Aishwarya | 767
RedHill Biopharma Announces Roll Out of Talicia in UAE
The commercial launch of Talicia in the UAE triggers RedHill's eligibility for additional potential milestone payments, minimum sales payments and tiered royalties up to mid-teens on net sales.
RedHill Biopharma | 23/08/2024 | By Aishwarya | 1233
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy